Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Hemoblock_S (Prescription); Hemoblock_S (OTC)

K-Number: K232216 · 2024-04-19

Decision Date2024-04-19
Product CodeQSY
DecisionSubstantially Equivalent

Device Summary

Hemoblock_S (Prescription); Hemoblock_S (OTC) is the device name listed in this FDA 510(k) record. The listed applicant is Incore Co., Ltd.. It received FDA 510(k) clearance on 2024-04-19 under 510(k) number K232216. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Hemoblock_S (Prescription); Hemoblock_S (OTC)?

Hemoblock_S (Prescription); Hemoblock_S (OTC) is a medical device that received FDA 510(k) clearance on 2024-04-19. The listed applicant is Incore Co., Ltd.. The 510(k) number is K232216.

When did Hemoblock_S (Prescription); Hemoblock_S (OTC) receive FDA 510(k) clearance?

Hemoblock_S (Prescription); Hemoblock_S (OTC) received FDA 510(k) clearance on 2024-04-19, under 510(k) number K232216.

Who is the listed applicant for Hemoblock_S (Prescription); Hemoblock_S (OTC)?

The FDA 510(k) record lists Incore Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Hemoblock_S (Prescription); Hemoblock_S (OTC)?

The FDA product code for Hemoblock_S (Prescription); Hemoblock_S (OTC) is QSY.

Other records listing Incore Co., Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: QSY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.